{"schema_version":"secwatch.filing_event.v1","accession":"0000888491-23-000021","form_type":"8-K","ticker":"OHI","cik":"0000888491","company_name":"OMEGA HEALTHCARE INVESTORS INC","filed_at":"2023-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.893566+00:00","generated_at":"2026-06-12T15:55:24.585116+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Omega Healthcare Q2 net income $0.25/share, down from $0.38 YoY; AFFO $0.74","bullets":["Net income $62M ($0.25 per share) vs $92M ($0.38) in Q2 2022.","Nareit FFO $155M ($0.63/share); AFFO $183M ($0.74/share), both down YoY.","Completed $270M in new investments: $129M acquisitions, $124M loans, $17M capex.","Sold 10 facilities for $45M cash, generating $12M gain; dividend maintained at $0.67/share.","Repaid $350M senior unsecured notes due Aug 1, 2023, during Q3 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000888491-23-000021","json":"https://secwatch.observer/filing/0000888491-23-000021.json","markdown":"https://secwatch.observer/filing/0000888491-23-000021.md","text":"https://secwatch.observer/filing/0000888491-23-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/888491/000088849123000021/0000888491-23-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/888491/000088849123000021/ohi-20230802x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T15:55:24.585116+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"703bd430ff8843d6419bbac3dddc7916276bddf7","claim":"OMEGA HEALTHCARE INVESTORS INC reported the quarter ended June 30, 2023 results: net income $62 million, or $0.25 per common share.","evidence_excerpt":"Net income for the quarter of $62 million, or $0.25 per common share, compared to $92 million, or $0.38 per common share, for the same period in 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/888491/000088849123000021/0000888491-23-000021-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Net income","value":"$62 million, or $0.25 per common share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}